Loading...

J&J blames price cuts in India for poor knee-implant business

 18-Oct-17, ET Healthworld 

Drug giant Johnson & Johnson took a USD10 mn (INR65 crore) hit on its international knee implant business in the July-September quarter, which it blamed on price cuts in India.

JnJ blames price cuts in India for poor knee implant business (c) ET Healthworld

Image: ET Healthworld

The US company called India’s decision to limit prices of stents and knee implants one of the "extreme examples of what it has seen in other marketplace."

The company's medical device business saw the knee implant business decline to USD343 mn from USD355 mn for the third quarter through September. Revenue in the segment’s international business, which includes India, fell to USD122 mn from USD132 mn.

 Read the full article 

 Insights 

Share